Secondary progressive multiple sclerosis: current knowledge and future challenges

@article{Rovaris2006SecondaryPM,
  title={Secondary progressive multiple sclerosis: current knowledge and future challenges},
  author={M. Rovaris and C. Confavreux and R. Furlan and L. Kappos and M. Filippi},
  journal={The Lancet Neurology},
  year={2006},
  volume={5},
  pages={343-354}
}
  • M. Rovaris, C. Confavreux, +2 authors M. Filippi
  • Published 2006
  • Medicine
  • The Lancet Neurology
    • The secondary progressive phase of multiple sclerosis (MS), which is characterised by a steady accrual of fixed disability after an initial relapsing remitting course, is not clearly understood. Although there is no consensus on the mechanisms underlying such a transition to the progressive phase, epidemiological and neuroimaging studies indicate that it is probably driven by the high prevalence of neurodegenerative compared with inflammatory pathological changes. This notion is lent support by… CONTINUE READING
    View on Elsevier
    doi.org
    247 Citations
    Highly Influencial Citations
    12
    Background Citations
    107
    Methods Citations
    3
    Results Citations
    9

    Topics from this paper

    Explore Further: Topics Discussed in This Paper

      Paper Mentions

      Interventional Clinical Trial
      Domperidone in Secondary Progressive Multiple Sclerosis (SPMS)
      The purpose of this clinical trial is to determine if Domperidone in a dose of 40 mg daily can prevent worsening of walking ability in people secondary progressive MS. The number of… Expand
      ConditionsMultiple Sclerosis, Secondary Progressive
      InterventionDrug
      University of Calgary
      February 2015 - January 2020
      247 Citations
      Citation Type

      Citation Type

      MULTIPLE SCLEROSIS: THERAPEUTIC FRONTIERS AND PROGRESSIVE DISEASE *
      Pharmacological Approaches to the Management of Secondary Progressive Multiple Sclerosis
      • 15
      Secondary Progressive Multiple Sclerosis: What is in the
      • 7
      • PDF
      Treatment trials in progressive MS—current challenges and future directions
      • 36
      Secondary Progressive Multiple Sclerosis: Definition and Measurement
      • 23
      • PDF
      Progressive multiple sclerosis: from pathogenic mechanisms to treatment.
      • 143
      • PDF
      The natural history of secondary progressive multiple sclerosis
      • 213
      • PDF
      Natural history comparisons of primary and secondary progressive multiple sclerosis reveals differences and similarities
      • 61
      Progression in multiple sclerosis: Further evidence of an age dependent process
      • 79
      Sequencing of high-efficacy disease-modifying therapies in multiple sclerosis: perspectives and approaches
      • 4

      References

      SHOWING 1-10 OF 148 REFERENCES
      The natural history of multiple sclerosis
      • 73
      Course and prognosis of chronic progressive multiple sclerosis: Results of an epidemiological study
      • 117
      Primary and secondary progressive multiple sclerosis
      • 41
      Long-term follow up of patients with clinically isolated syndromes, relapsing-remitting and secondary progressive multiple sclerosis
      • 180
      Prognostic factors for progression of disability in the secondary progressive phase of multiple sclerosis
      • 105
      The window of therapeutic opportunity in multiple sclerosis
      • 447
      Secondary progressive multiple sclerosis: the relationship between short-term MRI activity and clinical features.
      • 46
      • PDF
      A comparison of the pathology of primary and secondary progressive multiple sclerosis.
      • 286
      Primary and transitional progressive MS
      • 140
      Primary progressive multiple sclerosis.
      • 236
      • PDF